rs774871855
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_019606.6(MEPCE):c.109G>A(p.Glu37Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000097 in 1,268,484 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019606.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152082Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000639 AC: 1AN: 1564Hom.: 0 AF XY: 0.000982 AC XY: 1AN XY: 1018
GnomAD4 exome AF: 0.0000887 AC: 99AN: 1116402Hom.: 0 Cov.: 30 AF XY: 0.0000922 AC XY: 49AN XY: 531514
GnomAD4 genome AF: 0.000158 AC: 24AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.109G>A (p.E37K) alteration is located in exon 1 (coding exon 1) of the MEPCE gene. This alteration results from a G to A substitution at nucleotide position 109, causing the glutamic acid (E) at amino acid position 37 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at